Large-scale association studies of cerebrospinal fluid levels of Aβ42 and tau/p-tau have successfully identified variants in several genes that alter risk or rate of progression of Alzheimer's disease [147–149]. The gene discussed is MAPT; the disease is early-onset autosomal dominant Alzheimer disease.